Current status of amyloid-targeting immunotherapies for Alzheimer’s disease
G. Travis Tabor, David M. Holtzman
Abstract
Anti-amyloid antibodies are moving from clinical trials into patients to treat early clinical stages of Alzheimer's disease.
Topics & Concepts
DiseaseMedicineAmyloid βAmyloid (mycology)Alzheimer's diseaseImmunotherapyNeuroscienceImmunologyImmune systemBiologyPathologyAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesTryptophan and brain disorders